Sanofi and Alphabet’s life sciences firm Verily are investing $500M in a diabetes JV
Sanofi and Alphabet’s life sciences firm Verily are investing about $500M in a diabetes joint venture combining devices with services, an example of growing ties between the pharma and tech sectors. “The company will leverage […]